22415062|t|Plasmin system of Alzheimer's disease patients: CSF analysis.
22415062|a|Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by the extracellular deposit of Amyloid beta (Abeta), mainly of the Amyloid beta(1-42) (Abeta(1-42)) peptide in the hippocampus and neocortex leading to progressive cognitive decline and dementia. The possible imbalance between the Abeta production/degradation process was suggested to contribute to the pathogenesis of AD. Among others, the serine protease plasmin has shown to be involved in Abeta(1-42) clearance, a hypothesis strengthened by neuropathological studies on AD brains. To explore whether there is a change in plasmin system in CSF of AD patients, we analyzed CSF samples from AD and age-matched controls, looking at plasminogen, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) protein levels and t-PA and urokinase plasminogen activator (u-PA) enzymatic activities. We also measured Abeta(1-42), total-tau and phospho-tau (181) CSF levels and sought for a possible relationship between them and plasmin system values. Our findings showed that t-PA, plasminogen and PAI-1 levels, as t-PA enzymatic activity, remained unchanged in AD with respect to controls; u-PA activity was not detected. We conclude that CSF analysis of plasminogen system does not reflect changes observed post-mortem. Unfortunately, the CSF detection of plasmin system could not be a useful biomarker for either AD diagnosis or disease progression. However, these findings do not exclude the possible involvement of the plasmin system in AD.
22415062	0	7	Plasmin	Gene	5340
22415062	18	37	Alzheimer's disease	Disease	MESH:D000544
22415062	38	46	patients	Species	9606
22415062	62	81	Alzheimer's disease	Disease	MESH:D000544
22415062	83	85	AD	Disease	MESH:D000544
22415062	107	133	neurodegenerative disorder	Disease	MESH:D019636
22415062	180	192	Amyloid beta	Gene	351
22415062	194	199	Abeta	Gene	351
22415062	216	234	Amyloid beta(1-42)	Gene	351
22415062	313	330	cognitive decline	Disease	MESH:D003072
22415062	335	343	dementia	Disease	MESH:D003704
22415062	380	385	Abeta	Gene	351
22415062	468	470	AD	Disease	MESH:D000544
22415062	506	513	plasmin	Gene	5340
22415062	623	625	AD	Disease	MESH:D000544
22415062	674	681	plasmin	Gene	5340
22415062	699	701	AD	Disease	MESH:D000544
22415062	702	710	patients	Species	9606
22415062	741	743	AD	Disease	MESH:D000544
22415062	781	792	plasminogen	Gene	5340
22415062	794	822	tissue plasminogen activator	Gene	5327
22415062	824	828	t-PA	Gene	5327
22415062	867	872	PAI-1	Gene	5054
22415062	893	897	t-PA	Gene	5327
22415062	902	933	urokinase plasminogen activator	Gene	5328
22415062	935	939	u-PA	Gene	5328
22415062	999	1002	tau	Gene	4137
22415062	1015	1018	tau	Gene	4137
22415062	1092	1099	plasmin	Gene	5340
22415062	1140	1144	t-PA	Gene	5327
22415062	1146	1157	plasminogen	Gene	5340
22415062	1162	1167	PAI-1	Gene	5054
22415062	1179	1183	t-PA	Gene	5327
22415062	1226	1228	AD	Disease	MESH:D000544
22415062	1255	1259	u-PA	Gene	5328
22415062	1320	1331	plasminogen	Gene	5340
22415062	1422	1429	plasmin	Gene	5340
22415062	1480	1482	AD	Disease	MESH:D000544
22415062	1588	1595	plasmin	Gene	5340
22415062	1606	1608	AD	Disease	MESH:D000544
22415062	Association	MESH:D000544	351
22415062	Association	MESH:D003704	351

